Femasys Inc reports results for the quarter ended June 30 - Earnings Summary

Femasys

14/08/2026 21:59

Femasys Inc FEMY.OQ reported a quarterly adjusted loss of $1.55​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-3.00.  The mean expectation of three analysts for the quarter was for a loss of $1.30 per share. Wall Street expected results to range from $-1.60 to -100 cents per share.
Revenue fell 29.2% to $332.00 thousand from a year ago; analysts expected $730.67 thousand. 
Femasys Inc's reported EPS for the quarter was a loss of $1.33​.
The company reported a quarterly loss of $4.47 million.
Femasys Inc shares had fallen by 45.2% this quarter and lost 80.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for Femasys Inc is $30.00, about 92.4% above its last closing price of $2.29
This summary was machine generated from LSEG data August 14 at 08:59 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-1.30
-1.55
Missed
Mar. 31 2026 
-1.80
-1.20
Beat
Dec. 31 2025 
-1.75
-0.20
Beat
Sep. 30 2025 
-2.60
-2.00
Beat